The study, published on Cell & Bioscience, includes two experimental approaches, one with mice and the other one with cell cultures. This discovery may be the basis for the development of better treatments for this disease and means a paradigm shift.
Today, the UB and the biomedical company Atrys Health, specialized in precision medicine, have signed a collaboration agreement to create the Personalized Radiotherapy Chair, which will be led by Ferran Guedea, head of the IDIBELL Radiobiology and Cancer Group.
New chair to promote research in precision radiation oncology Read More »
IDIBELL will receive almost 630,000 euros from La Marató de TV3 and Catalunya Radio to carry out five projects. The funded studies will focus on the research of factors to predict COVID-19 complications and testing vaccines in vulnerable patients.
Five IDIBELL’s projects receive funding from La Marató 2020 dedicated to COVID-19 Read More »
Identification of the miR-518d-5p molecule in blood is associated with increased resistance to sorafenib treatment and reduced overall survival in patients with hepatocellular carcinoma
A study by IDIBELL and UB shows that participation in a workshop combining scientific training and theatre performance reduces implicit biases against physical illnesses
Science and performing arts against stereotypes Read More »
A study of IDIBELL, ICO, and Bellvitge University Hospital shows that exercise not only prevents the loss of neuronal tissue caused by chemotherapy and radiotherapy. Also, patients who follow sports guidelines increase the volume of gray matter in the brain regions involved in memory and learning functions, such as the hippocampus.
Exercise prevents neuronal damage caused by lung cancer treatment Read More »
An international study, with the participation of IDIBELL and ICO, determines that the metabolism of breast tumor cells is defined by their origin.
A work coordinated by Isabel Fabregat – group leader of TGF-β and Cancer group at IDIBELL and CIBEREHD – University of Barcelona – studies the reprogramming of lipid metabolism and provides new perspectives for the possible use of fatty acids and mitochondrial oxidative metabolism in new pharmacological approaches to decrease the metastasis of hepatocellular carcinoma.
Researchers from IDIBELL and ICO have used an orthotopic mouse model to expand the myeloma patient’s tumor tissue to study his molecular characteristics and response to different treatments.
A mouse model to predict the response to the treatment of a myeloma patient Read More »
The Tobacco Control Research Group has received one of the World No Tobacco Day 2021 Awards from the World Health Organization for their work in the field of tobacco control.
Tobacco Control Research Groups awarded by the WHO Read More »
